{"id":145655,"date":"2023-05-10T08:05:29","date_gmt":"2023-05-10T12:05:29","guid":{"rendered":"https:\/\/44.250.171.167\/?p=145655"},"modified":"2023-05-10T08:05:30","modified_gmt":"2023-05-10T12:05:30","slug":"lupin-limited-q4fy23-earnings-story","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/lupin-limited-q4fy23-earnings-story\/","title":{"rendered":"Lupin Limited Q4FY23 Earnings Story"},"content":{"rendered":"\n<p>Lupin manufactures pharmaceuticals as a line of business. Globally, APIs, biotechnology products, and generic formulations are all developed and marketed by Lupin Limited. The firm\u00a0is a worldwide leader in the Anti-TB and Cephalosporins segments and has a substantial presence in the Cardiovascular, Diabetology, Asthma, Paediatrics, and Central Nervous system markets, among others.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<br><\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Lupin Ltd. reported Total Income for Q4FY23 of \u20b9 4,430 Crores up from \u20b9 3,883 Crore year on year, a rise of 14%.<br><br><\/li><li>Total Expenses for Q4FY23 of \u20b9 4,209 Crores up from \u20b9 3,984 Crores year on year, rise of 6%.<br><br>\u00a0<\/li><li>Consolidated Net Profit of \u20b9 259 Crores, up from a loss of \u20b9 850 Crores in the same quarter of the previous year.<br><br>\u00a0<\/li><li>The Earnings per Share is \u20b9 5.16, down 62% from \u20b9 -11.40 in the same quarter of the previous year.<\/li><\/ul>\n\n\n\n<div class=\"wp-block-image is-style-default\"><figure class=\"aligncenter size-large is-resized\"><a href=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-19.png\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-19.png\" alt=\"\" class=\"wp-image-145656\" width=\"231\" height=\"330\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-19.png 275w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/image-19-210x300.png 210w\" sizes=\"auto, (max-width: 231px) 100vw, 231px\" \/><\/a><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lupin manufactures pharmaceuticals as a line of business. Globally, APIs, biotechnology products, and generic formulations are all developed and marketed by Lupin Limited. The firm\u00a0is a worldwide leader in the Anti-TB and Cephalosporins segments and has a substantial presence in the Cardiovascular, Diabetology, Asthma, Paediatrics, and Central Nervous system markets, among others. Financial Results: Lupin [&hellip;]<\/p>\n","protected":false},"author":1885,"featured_media":138549,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5747],"tags":[10162],"class_list":["post-145655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-healthcare-stocks","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":166808,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q3fy25-39-rise-in-profits\/","url_meta":{"origin":145655,"position":0},"title":"Lupin Ltd Q3FY25; 39% rise in Profits","author":"Chirag Gupta","date":"February 12, 2025","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168697,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q4fy25-112-rise-in-profits\/","url_meta":{"origin":145655,"position":1},"title":"Lupin Ltd Q4FY25; 112% rise in Profits","author":"Chirag Gupta","date":"June 6, 2025","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/3-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151230,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q1fy24-29-rise-in-revenue\/","url_meta":{"origin":145655,"position":2},"title":"Lupin Ltd Q1FY24; 29% rise in Revenue","author":"Karan_Singh","date":"August 4, 2023","format":false,"excerpt":"Lupin is engaged in the business of Manufacture of Pharmaceuticals. Financial Results: Lupin Ltd reported Revenues for Q1FY24 of \u20b94,814.00 Crores up from \u20b93,744.00 Crore year on year, a rise of 28.58%. Total Expenses for Q1FY24 of \u20b94,279.00 Crores up from \u20b93,748.00 Crores year on year, a rise of 14.17%.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-186.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":163810,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q1fy25-78-rise-in-profits\/","url_meta":{"origin":145655,"position":3},"title":"Lupin Ltd Q1FY25; 78% rise in Profits","author":"Chirag Gupta","date":"August 13, 2024","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-87.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":160871,"url":"https:\/\/alphastreet.com\/india\/lupin-ltd-q4fy24-52-rise-in-profits\/","url_meta":{"origin":145655,"position":4},"title":"Lupin Ltd Q4FY24; 52% rise in Profits","author":"Chirag Gupta","date":"May 6, 2024","format":false,"excerpt":"Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-36.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":148011,"url":"https:\/\/alphastreet.com\/india\/la-opala-rg-limited-q4fy23-earnings-story\/","url_meta":{"origin":145655,"position":5},"title":"La Opala RG Limited Q4FY23 Earnings Story","author":"Karan_Singh","date":"June 1, 2023","format":false,"excerpt":"Leading glass and opal dinnerware producers and marketers in India are La Opala RG. Financial Results: La Opala RG Limited reported Total Income for Q4FY23 of \u20b9 116 Crores up from \u20b9 94 Crore year on year, a rise of 23%.Total Expenses for Q4FY23 of \u20b9 76 Crores up from\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1385606617.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1385606617.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1385606617.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/iStock-1385606617.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/145655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=145655"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/145655\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/138549"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=145655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=145655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=145655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}